Medicare Home Infusion Therapy Access Act of 2017

S.1738: Medicare Home Infusion Therapy Access Act of 2017 - home infusion Medicare reimbursement rate transition

Client expense: Not reported · Firm income: $40,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS)

Issues related to patient infusion therapy, medical device tax, Medicare reimbursements for tracheotomy tubes, and medical device technology related to the opioid epidemic. Implementation of 21st Century Cures Act (P.L.114-255). S.1738, Medicare Home Infusion Therapy Access Act of 2017. H.R.3178, Medicare Part B Improvement Act of 2017. Implementation of H.R.3163, Medicare Part B Home Infusion Services Temporary Transitional Payment Act.

Client expense: $420,000 · Firm income: Not reported

Government targets: Army, Dept of (Other), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Energy, Dept of, Environmental Protection Agency (EPA), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Justice, Dept of (DOJ), Office of Policy Development, SENATE, Transportation Security Administration (TSA), U.S. Customs & Border Protection, U.S. Trade Representative (USTR)

FAST Genetics Act of 2017 (H.R. 2051) CREATES Act of 2017 (H.R. 2212/S. 974) Preserve Access to Affordable Generics Act (S. 124) 340B PAUSE ACT (H.R. 4710) Legislation to place a moratorium on the 340B drug payment cuts in the CY 2018 Outpatient Prospective Payment System Rule (H.R. 4392) Protecting Jessica Grubbs Legacy Act (S. 1850) Overdose Prevention and Patient Safety Act (H.R. 3545, 5795, 6082) ACA Medicaid disproportionate share hospital (DSH) cuts Childrens Health Insurance Program (CHIP) funding ACO Improvement Act of 2017 (H.R. 4580) Medicare Home Infusion Therapy Access Act of 2017 (S. 1738)/ Section 101 of Medicare Part B Improvement Act of 2017 (H.R. 3178) Prescription Drug Price Transparency Act (MAC bill) (H.R.1316) Improving Transparency and Accuracy in Medicare Part D Spending Act (H.R.1038/S.413) Ensuring Seniors Access to Local Pharmacies Act of 2017 (H.R.1939/S.1044) Pharmacy and Medically Underserved Areas Enhancement Act (H.R.592/S.109) CARA 2.0 Act of 2018 (H.R.5311/S.2456) Biosimilars Competition Act of 2018 (H.R. 6478) Know the Lowest Price Act of 2018 (S.2553) Patient Right to Know Drug Prices Act (S.2554) SUPPORT for Patients and Communities Act (H.R. 6)

Client expense: $310,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Medicare coverage and payment for immune globulin (IG) treatments; Part B reimbursement issues; S. 1738 (Medicare Home Infusion Therapy Access Act); evaluation of IVIG Demonstration

Client expense: Not reported · Firm income: $10,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

S.1738: Medicare Home Infusion Therapy Access Act of 2017 - home infusion Medicare reimbursement rate transition

Client expense: Not reported · Firm income: $30,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

FAST Genetics Act of 2017 (H.R. 2051) CREATES Act of 2017 (H.R. 2212/S. 974) Preserve Access to Affordable Generics Act (S. 124) 340B PAUSE ACT (H.R. 4710) Legislation to place a moratorium on the 340B drug payment cuts in the CY 2018 Outpatient Prospective Payment System Rule (H.R. 4392) Protecting Jessica Grubbs Legacy Act (S. 1850) Overdose Prevention and Patient Safety Act (H.R. 3545, 5795, 6082) ACA Medicaid disproportionate share hospital (DSH) cuts Childrens Health Insurance Program (CHIP) funding ACO Improvement Act of 2017 (H.R. 4580) Medicare Home Infusion Therapy Access Act of 2017 (S. 1738)/ Section 101 of Medicare Part B Improvement Act of 2017 (H.R. 3178) Prescription Drug Price Transparency Act (MAC bill) (H.R.1316) Improving Transparency and Accuracy in Medicare Part D Spending Act (H.R.1038/S.413) Ensuring Seniors Access to Local Pharmacies Act of 2017 (H.R.1939/S.1044) Pharmacy and Medically Underserved Areas Enhancement Act (H.R.592/S.109) CARA 2.0 Act of 2018 (H.R.5311/S.2456).

Client expense: $350,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S.1738: Medicare Home Infusion Therapy Access Act of 2017 - home infusion Medicare reimbursement rate transition

Client expense: Not reported · Firm income: $40,000

Government targets: Centers For Medicare and Medicaid Services (CMS)

Medicare coverage and payment for immune globulin (IG) treatments; Part B reimbursement issues; S. 1738 (Medicare Home Infusion Therapy Access Act); H.R. 3976 (Access to Marketplace Insurance Act)

Client expense: Not reported · Firm income: $10,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

114th Congress HR 605/S. 275 - Reintroduction of The Medicare Home Infusion Site of Care Act HR 3178, S. 1738, HR 3163, HR 1892 - lobbied House and Senate, CMS on proper implementation of the legislation. H.R.4724 - Medicare IVIG Access Enhancement Act, technical assistance

Client expense: $80,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Issues related to patient infusion therapy, medical device tax, Medicare reimbursements for tracheotomy tubes, and medical device technology related to the opioid epidemic. Implementation of 21st Century Cures Act (P.L.114-255). S.1738, Medicare Home Infusion Therapy Access Act of 2017. H.R.3178, Medicare Part B Improvement Act of 2017. H.R.3163, Medicare Part B Home Infusion Services Temporary Transitional Payment Act. S.3120, An original bill to amend titles XVIII and XIX of the Social Security Act to help end addictions and lessen substance abuse disorders, and for other purposes. H.R.6, SUPPORT for Patients and Communities Act.

Client expense: $410,000 · Firm income: Not reported

Government targets: Army, Dept of (Other), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Energy, Dept of, Environmental Protection Agency (EPA), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Justice, Dept of (DOJ), Office of Policy Development, SENATE, Transportation Security Administration (TSA), U.S. Customs & Border Protection, U.S. Trade Representative (USTR)

Patient infusion therapy and reimbursement/policy issues related to non-opioid acute pain management. S.1738, Medicare Home Infusion Therapy Access Act of 2017. H.R.3178, Medicare Part B Improvement Act of 2017. H.R.3163, Medicare Part B Home Infusion Services Temporary Transitional Payment Act. S.3120, An original bill to amend titles XVIII and XIX of the Social Security Act to help end addictions and lessen substance abuse disorders, and for other purposes. H.R.6, SUPPORT for Patients and Communities Act.

Client expense: $410,000 · Firm income: Not reported

Government targets: Army, Dept of (Other), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Energy, Dept of, Environmental Protection Agency (EPA), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Justice, Dept of (DOJ), Office of Policy Development, SENATE, Transportation Security Administration (TSA), U.S. Customs & Border Protection, U.S. Trade Representative (USTR)

Issues related to home infusion therapy; S.1738

Client expense: Not reported · Firm income: $10,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issues related to prescription drug abuse, Medicare Part D, and Medicare payment for home infusion. S.413/H.R. 1039, The Improving Transparency and Accuracy in Medicare Part D Spending Act of 2017 H.R.1316, The Prescription Drug Price Transparency Act of 2017 S. 2460/H.R. 3528, The Every Prescription Conveyed Safely Act of 2017 S. 1738/H.R. 3163, The Medicare Home Infusion Therapy Act of 2017 H.R. 3178, The Medicare Part B Improvement Act of 2017 S. 2553, The Know the Lowest Price Act of 2018 H.R. 4841, The Standardizing Electronic Prior Authorization for Safe Prescribing Act

Client expense: $1,803,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE

FAST Genetics Act of 2017 (H.R. 2051) CREATES Act of 2017 (H.R. 2212/S. 974) Preserve Access to Affordable Generics Act (S. 124) 340B PAUSE ACT (H.R. 4710) Legislation to place a moratorium on the 340B drug payment cuts in the CY 2018 Outpatient Prospective Payment System Rule (H.R. 4392) Protecting Jessica Grubbs Legacy Act (S. 1850) Overdose Prevention and Patient Safety Act (H.R. 3545) ACA Medicaid disproportionate share hospital (DSH) cuts Childrens Health Insurance Program (CHIP) funding ACO Improvement Act of 2017 (H.R. 4580) Medicare Home Infusion Therapy Access Act of 2017 (S. 1738)/ Section 101 of Medicare Part B Improvement Act of 2017 (H.R. 3178) Prescription Drug Price Transparency Act (MAC bill) (H.R.1316) Improving Transparency and Accuracy in Medicare Part D Spending Act (H.R.1038/S.413) Ensuring Seniors Access to Local Pharmacies Act of 2017 (H.R.1939/S.1044) Pharmacy and Medically Underserved Areas Enhancement Act (H.R.592/S.109)

Client expense: $630,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S.1738, Medicare Home Infusion Therapy Access Act of 2017; H.R.3178, Medicare Part B Improvement Act of 2017; H.R.3163, Medicare Part B Home Infusion Services Temporary Transitional Payment Act; issues related to patient infusion therapy. Reimbursement and policy issues related to non-opioid acute pain management.

Client expense: $510,000 · Firm income: Not reported

Government targets: Army, Dept of (Other), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Energy, Dept of, Environmental Protection Agency (EPA), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Justice, Dept of (DOJ), Office of Policy Development, SENATE, Transportation Security Administration (TSA), U.S. Customs & Border Protection, U.S. Trade Representative (USTR)

Implementation of 21st Century Cures Act (P.L.114-255); S.1738, Medicare Home Infusion Therapy Access Act of 2017; H.R.3178, Medicare Part B Improvement Act of 2017; H.R.3163, Medicare Part B Home Infusion Services Temporary Transitional Payment Act; issues related to patient infusion therapy. H.R.195, Making further continuing appropriations for the fiscal year ending September 30, 2018, and for other purposes (P.L.115-120); H.R.1892, Bipartisan Budget Act of 2018 (P.L.115-123); issues related to the medical device tax. Issues related to Medicare reimbursements for tracheotomy tubes. Medical device technology related to the opioid epidemic.

Client expense: $510,000 · Firm income: Not reported

Government targets: Army, Dept of (Other), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Energy, Dept of, Environmental Protection Agency (EPA), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Justice, Dept of (DOJ), Office of Policy Development, SENATE, Transportation Security Administration (TSA), U.S. Customs & Border Protection, U.S. Trade Representative (USTR)

Medicare issues including reimbursement and home infusion therapy in Part B DME (durable medical equipment); Implementation of P.L.114-255, 21st Century Cures Act; H.R.3178, Medicare Part B Improvement Act of 2017; S.1738, Medicare Home Infusion Therapy Access Act of 2017; H.R.1892, Bipartisan Budget Act of 2018 (P.L.115-123).

Client expense: Not reported · Firm income: $50,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issues related to home infusion therapy; S.1738

Client expense: Not reported · Firm income: $10,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S.1738: Medicare Home Infusion Therapy Access Act of 2017 - home infusion Medicare reimbursement rate transition

Client expense: Not reported · Firm income: $30,000

Government targets: Centers For Medicare and Medicaid Services (CMS)

The Affordable Care Act, provisions relating to essential health benefits and patient protections. HR 1628, The American Health Care Act, sections pertaining to essential health benefits, lifetime caps and affordability. Senate Better Care Reconciliation Act sections relating to essential health benefits, lifetime caps and affordability. HR 34, 21st Century Cures, relating to payment of pharmacy services for home infusion drugs in DME products. Legislation to extend the duration of the IVIG demonstration project.HR 3178, the Medicare Part B Improvement Act of 2017, provisions relating to the Medicare IVIG Demonstration Extension Act of 2017 and the Medicare Part B Infusion Services Temporary Transitional Payment Act. S. 1738, The Medicare Home Infusion Therapy Access Act of 2017 HR 3163 - Medicare Part B Home Infusion Services Temporary Transitional Payment Act, sections pertaining to payment of pharmacy fees. H.R.4724 - Medicare IVIG Access Enhancement Act - provisions relating to the development and funding for a demonstration project.

Client expense: $210,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE

114th Congress HR 605/S. 275 - Reintroduction of The Medicare Home Infusion Site of Care Act HR 3178, S. 1738, HR 3163, HR 1892 - lobbied House and Senate for temporary transitional home infusion clinical services reimbursement H.R.4724 - Medicare IVIG Access Enhancement Act, technical assistance

Client expense: $130,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

H.R. 1892, Bipartisan Budget Act, H.R. 3178, Medicare Part B Improvement Act of 2017, and S. 1738, The Medicare Home Infusion Therapy Access Act of 2017 and issues related to reimbursement for home infusion. Issues related to pharmaceutical prices. Issues regarding the Self-Administered Drug (SAD) list. H.R. 1625, Consolidated Appropriations Act of 2018.

Client expense: Not reported · Firm income: $52,500

Government targets: HOUSE OF REPRESENTATIVES, Office of the Vice President of the United States, SENATE

Medicare coverage and payment for immune globulin (IG) treatments; Part B reimbursement issues; S. 1738 (Medicare Home Infusion Therapy Access Act); H.R. 3976 (Access to Marketplace Insurance Act)

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R.3163 - To amend title XVIII of the Social Security Act to provide for a home infusion therapy services temporary transitional payment under the Medicare program. H.R.3178 - Medicare Part B Improvement Act of 2017 S.1738 - Medicare Home Infusion Therapy Access Act of 2017

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R.3163 - To amend title XVIII of the Social Security Act to provide for a home infusion therapy services temporary transitional payment under the Medicare program. H.R.3178 - Medicare Part B Improvement Act of 2017 S.1738 - Medicare Home Infusion Therapy Access Act of 2017

Client expense: Not reported · Firm income: $10,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S.1738, Medicare Home Infusion Therapy Access Act of 2017; H.R.3178, Medicare Part B Improvement Act of 2017; issues related to patient infusion therapy. Reimbursement and policy issues related to non-opioid acute pain management.

Client expense: $590,000 · Firm income: Not reported

Government targets: Army, Dept of (Other), Defense, Dept of (DOD), Energy, Dept of, Environmental Protection Agency (EPA), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Justice, Dept of (DOJ), Office of Policy Development, SENATE, Transportation Security Administration (TSA), U.S. Customs & Border Protection, U.S. Trade Representative (USTR)

Implementation of 21st Century Cures Act (P.L.114-255); S.1738, Medicare Home Infusion Therapy Access Act of 2017; H.R.3178, Medicare Part B Improvement Act of 2017; issues related to patient infusion therapy. H.R.1628, American Health Care Act of 2017/Better Care Reconciliation Act of 2017; issues related to the medical device tax. Issues related to Medicare reimbursements for tracheotomy tubes. Medical device technology related to the opioid epidemic.

Client expense: $590,000 · Firm income: Not reported

Government targets: Army, Dept of (Other), Defense, Dept of (DOD), Energy, Dept of, Environmental Protection Agency (EPA), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Justice, Dept of (DOJ), Office of Policy Development, SENATE, Transportation Security Administration (TSA), U.S. Customs & Border Protection, U.S. Trade Representative (USTR)

Implementation of 21st Century Cures Act (P.L.114-255); S.1738, Medicare Home Infusion Therapy Access Act of 2017; H.R.3178, Medicare Part B Improvement Act of 2017; issues related to patient infusion therapy. H.R.2430/S.934, FDA Reauthorization Act of 2017 (P.L.115-52); regulations related to Medical Device User Fee Amendments (MDUFA). H.R.1628, American Health Care Act of 2017/Better Care Reconciliation Act of 2017; issues related to the medical device tax. Issues related to Medicare reimbursements for tracheotomy tubes. Issues related to inspection process of medical device facilities. Medical device technology related to the opioid epidemic.

Client expense: $570,000 · Firm income: Not reported

Government targets: Army, Dept of (Other), Defense, Dept of (DOD), Energy, Dept of, Environmental Protection Agency (EPA), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Justice, Dept of (DOJ), Office of Policy Development, SENATE, Transportation Security Administration (TSA), U.S. Customs & Border Protection, U.S. Trade Representative (USTR)

S.1738, Medicare Home Infusion Therapy Access Act of 2017; H.R.3178, Medicare Part B Improvement Act of 2017; issues related to patient infusion therapy. Reimbursement and policy issues related to non-opioid acute pain management.

Client expense: $570,000 · Firm income: Not reported

Government targets: Army, Dept of (Other), Defense, Dept of (DOD), Energy, Dept of, Environmental Protection Agency (EPA), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Justice, Dept of (DOJ), Office of Policy Development, SENATE, Transportation Security Administration (TSA), U.S. Customs & Border Protection, U.S. Trade Representative (USTR)

H.R. 3178, Medicare Part B Improvement Act of 2017 and S. 1738, The Medicare Home Infusion Therapy Access Act of 2017 and issues related to reimbursement for home infusion. Issues related to pharmaceutical prices. Issues regarding the Self-Administered Drug (SAD) list.

Client expense: Not reported · Firm income: $52,500

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issues related to Medicare Part D and Medicare payment for home infusion. S.413/H.R. 1039, The Improving Transparency and Accuracy in Medicare Part D Drug Spending Act of 2017 H.R.1316, The Prescription Drug Price Transparency Act of 2017 S.771/H.R. 1776, The Improving Access to Affordable Prescription Drugs Act of 2017 H.R. 3528, The Every Prescription Conveyed Safely Act of 2017 S. 1738/H.R. 3163, The Medicare Home Infusion Therapy Act of 2017 H.R. 3178, The Medicare Part B Improvement Act of 2017

Client expense: $1,680,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, Veterans Affairs, Dept of (VA), White House Office

FAST Genetics Act of 2017 (H.R. 2051) CREATES Act of 2017 (H.R. 2212/S. 974) Preserve Access to Affordable Generics Act (S. 124) 340B PAUSE ACT (H.R. 4710) Legislation to place a moratorium on the 340B drug payment cuts in the CY 2018 Outpatient Prospective Payment System Rule (H.R. 4392) Protecting Jessica Grubbs Legacy Act (S. 1850) Overdose Prevention and Patient Safety Act (H.R. 3545) ACA Medicaid disproportionate share hospital (DSH) cuts Childrens Health Insurance Program (CHIP) funding ACO Improvement Act of 2017 (H.R. 4580) Medicare Home Infusion Therapy Access Act of 2017 (S. 1738)/ Section 101 of Medicare Part B Improvement Act of 2017 (H.R. 3178) Prescription Drug Price Transparency Act (MAC bill) (H.R.1316) Improving Transparency and Accuracy in Medicare Part D Spending Act (H.R.1038/S.413) Ensuring Seniors Access to Local Pharmacies Act of 2017 (H.R.1939/S.1044) Pharmacy and Medically Underserved Areas Enhancement Act (H.R.592/S.109)

Client expense: $360,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

114th Congress HR 605/S. 275 - Reintroduction of The Medicare Home Infusion Site of Care Act HR 3178, S. 1738, HR 3163 - lobbied House and Senate for temporary transitional home infusion clinical services reimbursement HR 3178, HR 3172, HR 3823 - IVIG Coverage Demonstration - Lobbied House and Senate for extension of demonstration. H.R. 4229, lobbied in support of the Protecting Home Oxygen & Medical Equipment Access Act

Client expense: $100,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Implementation of 21st Century Cures Act (P.L.114-255); S.1738, Medicare Home Infusion Therapy Access Act of 2017; H.R.3178, Medicare Part B Improvement Act of 2017; issues related to patient infusion therapy. H.R.1628, American Health Care Act of 2017/Better Care Reconciliation Act of 2017; issues related to the medical device tax. Issues related to Medicare reimbursements for tracheotomy tubes. Medical device technology related to the opioid epidemic.

Client expense: $580,000 · Firm income: Not reported

Government targets: Army, Dept of (Other), Defense, Dept of (DOD), Energy, Dept of, Environmental Protection Agency (EPA), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Justice, Dept of (DOJ), Office of Policy Development, SENATE, Transportation Security Administration (TSA), U.S. Customs & Border Protection, U.S. Trade Representative (USTR)

S.1738, Medicare Home Infusion Therapy Access Act of 2017; H.R.3178, Medicare Part B Improvement Act of 2017; issues related to patient infusion therapy. Reimbursement and policy issues related to non-opioid acute pain management.

Client expense: $580,000 · Firm income: Not reported

Government targets: Army, Dept of (Other), Defense, Dept of (DOD), Energy, Dept of, Environmental Protection Agency (EPA), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Justice, Dept of (DOJ), Office of Policy Development, SENATE, Transportation Security Administration (TSA), U.S. Customs & Border Protection, U.S. Trade Representative (USTR)

access to home infusion services, S. 1738 Medicare Home Infusion Therapy Access Act.

Client expense: Not reported · Firm income: $10,000

Government targets: SENATE

S.1738: Medicare Home Infusion Therapy Access Act of 2017 - home infusion Medicare reimbursement rate transition

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Implementation of P.L.114-255, 21st Century Cures Act; H.R.3178, Medicare Part B Improvement Act of 2017; S.1738, Medicare Home Infusion Therapy Access Act of 2017; Medicare issues including reimbursement and home infusion therapy in Part B DME (durable medical equipment).

Client expense: Not reported · Firm income: $50,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

The Affordable Care Act, provisions relating to essential health benefits and patient protections. HR 1628, The American Health Care Act, sections pertaining to essential health benefits, lifetime caps and affordability. Senate Better Care Reconciliation Act sections relating to essential health benefits, lifetime caps and affordability. HR 34, 21st Century Cures, relating to payment of pharmacy services for home infusion drugs in DME products. Legislation to extend the duration of the IVIG demonstration project.HR 3178, the Medicare Part B Improvement Act of 2017, provisions relating to the Medicare IVIG Demonstration Extension Act of 2017 and the Medicare Part B Infusion Services Temporary Transitional Payment Act. S. 1738, The Medicare Home Infusion Therapy Access Act of 2017 HR 3163 - Medicare Part B Home Infusion Services Temporary Transitional Payment Act, sections pertaining to payment of pharmacy fees. H.R. 3823, the Disaster Tax Relief and Airport and Airway Extension Act of 2017 - Section 302 including the extension of the Medicare Patient Intravenous Immunoglobin (IVIG) Access Demonstration Project.

Client expense: $120,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE

340B Drug Discount Program - Opposed Medicare reimbursement reductions for hospitals eligible for the 340B drug discount program. Supported passage of H.R. 4392. Opposed H.R. 4710. Children's Health Insurance Program (H.R. 3922, Championing Healthy Kids Act) - Supported passing legislation to extend the Children's Health Insurance Program. Medicaid Disproportionate Share Hospital (DSH) Payments - Supported legislation (H.R. 3922) delaying implementation of Medicaid DSH payment cuts. Urged Congress to pass legislation to continue Medicare "extenders" (Medicare Dependent Hospital program, Low Volume Adjustment and ambulance add-on payments). Supported passage of the ACE Kids Act (S.428). Home Infusion Payments (S. 1738, H.R. 3178) - Supported making changes to align the effective dates of ASP reimbursement for Part B DME infusion drugs and infusion services payments. Medicare Site-neutral Payment Policies- Monitored proposals to reduce hospital payments to outpatient or physician office reimbursement levels.

Client expense: $175,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Issues related to home infusion therapy; S.1738

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Medicare coverage and payment for immune globulin (IG) treatments; Part B reimbursement issues; S. 1738 (Medicare Home Infusion Therapy Access Act)

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R.3163 - To amend title XVIII of the Social Security Act to provide for a home infusion therapy services temporary transitional payment under the Medicare program. H.R.3178 - Medicare Part B Improvement Act of 2017 S.1738 - Medicare Home Infusion Therapy Access Act of 2017

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

The Affordable Care Act, provisions relating to essential health benefits and patient protections. HR 1628, The American Health Care Act, sections pertaining to essential health benefits, lifetime caps and affordability. Senate Better Care Reconciliation Act sections relating to essential health benefits, lifetime caps and affordability. HR 34, 21st Century Cures, relating to payment of pharmacy services for home infusion drugs in DME products. Legislation to extend the duration of the IVIG demonstration project.HR 3178, the Medicare Part B Improvement Act of 2017, provisions relating to the Medicare IVIG Demonstration Extension Act of 2017 and the Medicare Part B Infusion Services Temporary Transitional Payment Act. S. 1738, The Medicare Home Infusion Therapy Access Act of 2017 HR 3163 - Medicare Part B Home Infusion Services Temporary Transitional Payment Act, sections pertaining to payment of pharmacy fees. H.R. 3823, the Disaster Tax Relief and Airport and Airway Extension Act of 2017 - Section 302 including the extension of the Medicare Patient Intravenous Immunoglobin (IVIG) Access Demonstration Project.

Client expense: $130,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE

Issues related to Medicare Part D and Medicare payment for home infusion. S.637, The Creating Transparency to Have Drug Rebates Unlocked Act of 2017 S.413/H.R. 1039, The Improving Transparency and Accuracy in Medicare Part D Drug Spending Act of 2017 S.771/H.R. 1776, The Improving Access to Affordable Prescription Drugs Act of 2017 H.R. 3528, The Every Prescription Conveyed Safely Act of 2017 S. 1738/H.R. 3163, The Medicare Home Infusion Therapy Act of 2017 H.R. 3178, The Medicare Part B Improvement Act of 2017 H.R. 3823, The Disaster Tax Relief and Airport and Airway Extension Act of 2017

Client expense: $1,450,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, Veterans Affairs, Dept of (VA), White House Office